Literature DB >> 21933867

Estimation of estradiol in mouse serum samples: evaluation of commercial estradiol immunoassays.

Daniel J Haisenleder1, Aleisha H Schoenfelder, Elizabeth S Marcinko, Lisa M Geddis, John C Marshall.   

Abstract

The University of Virginia Center for Research in Reproduction Ligand Core performed an evaluation of nine commercial estradiol (E2) immunoassays for use with mouse serum. The evaluation had two components. 1) Recovery Studies: a mouse pool was spiked with E2 concentrations across the assay range, and percent recovery and parallelism to the assay standard curve were determined. 2) Correlation Studies: serum pools were collected from intact females, ovariectomized (OVX) and OVX-E2 treated mice and E2 assayed, then measured by gas chromatography/tandem mass spectrometry (GC/MSMS) for comparison to a gold standard method. Recovery results showed that E2 recovery from spiked mouse pools varied greatly (from <18% to >640%) among kits tested. However, three kits (DiaSorin Radioimmunoassay, Siemens Double Antibody RIA, and CalBiotech Enzyme Immunoassay) showed reasonable recoveries and parallelism. Data collected from the Correlation Study showed that values from intact, OVX and OVX-E2-treated mouse pools varied by several fold vs. GC/MSMS for most of the kits tested. The DiaSorin RIA and CalBiotech Enzyme Immunoassay Kits showed the best correlation to GC/MSMS. Unfortunately, while this evaluation was ongoing, the DiaSorin Kit was discontinued. In summary, the CalBiotech Kit was the only available assay tested that demonstrated good E2 parallelism to the assay standard curve and accuracy vs. a gold standard method (i.e. GC/MSMS). Also of note, the CalBiotech assay is sensitive and requires minimal sample volume. Therefore, based on these findings the CalBiotech E2 assay has been implemented for use in mouse serum samples within the Ligand Core.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933867      PMCID: PMC3198998          DOI: 10.1210/en.2011-1501

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Specificity of immunoassays. I. Effect of plasma proteins on the specificity of steroid immunoassay.

Authors:  J J Pratt; W Koops; M G Woldring; T Wiegman
Journal:  Eur J Nucl Med       Date:  1976

Review 2.  Approaches to minimizing interference by cross-reacting molecules in immunoassays.

Authors:  J J Miller; R Valdes
Journal:  Clin Chem       Date:  1991-02       Impact factor: 8.327

Review 3.  Steroid immunoassay in clinical chemistry.

Authors:  J J Pratt
Journal:  Clin Chem       Date:  1978-11       Impact factor: 8.327

4.  Specificity of immunoassays. II. Heterogeneity of specificity of antibodies in antisera used for steroid immunoassay and the selective blocking of less specific antibodies, including a new method for the measurement of immunoassay specificity.

Authors:  J J Pratt; M G Woldring; R Boonman; J Kittikool
Journal:  Eur J Nucl Med       Date:  1979-06-01

Review 5.  Low endogenous estrogen levels--analytical problems and tissue sensitivity.

Authors:  K Carlström
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1996

6.  Estradiol-17 beta determined in plasma by gas chromatography-mass spectrometry with selected ion monitoring of mixed silyl ether-perfluoroacyl ester derivatives and use of various stable-isotope-labeled internal standards.

Authors:  L Dehennin
Journal:  Clin Chem       Date:  1989-04       Impact factor: 8.327

7.  Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma.

Authors:  Robert E Nelson; Stefan K Grebe; Dennis J OKane; Ravinder J Singh
Journal:  Clin Chem       Date:  2003-12-04       Impact factor: 8.327

Review 8.  Steroid hormone analysis by tandem mass spectrometry.

Authors:  Steven J Soldin; Offie P Soldin
Journal:  Clin Chem       Date:  2009-03-26       Impact factor: 8.327

9.  Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy.

Authors:  Richard J Santen; Lawrence Demers; Susan Ohorodnik; J Settlage; Peter Langecker; D Blanchett; Paul E Goss; Shuping Wang
Journal:  Steroids       Date:  2007-05-21       Impact factor: 2.668

  9 in total
  66 in total

1.  Low doses of 17β-estradiol rapidly improve learning and increase hippocampal dendritic spines.

Authors:  Anna Phan; Christopher S Gabor; Kayla J Favaro; Shayna Kaschack; John N Armstrong; Neil J MacLusky; Elena Choleris
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  GnRH Receptor Expression and Reproductive Function Depend on JUN in GnRH Receptor‒Expressing Cells.

Authors:  Carrie R Jonak; Nancy M Lainez; Ulrich Boehm; Djurdjica Coss
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

3.  Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Authors:  Ulla Simanainen; Yan Ru Gao; Kirsty A Walters; Geoff Watson; Reena Desai; Mark Jimenez; David J Handelsman
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

4.  Steroid assays and endocrinology: best practices for basic scientists.

Authors:  Richard J Auchus
Journal:  Endocrinology       Date:  2014-06       Impact factor: 4.736

5.  c-JUN Dimerization Protein 2 (JDP2) Is a Transcriptional Repressor of Follicle-stimulating Hormone β (FSHβ) and Is Required for Preventing Premature Reproductive Senescence in Female Mice.

Authors:  Carrie R Jonak; Nancy M Lainez; Lacey L Roybal; Alexa D Williamson; Djurdjica Coss
Journal:  J Biol Chem       Date:  2016-12-22       Impact factor: 5.157

6.  FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.

Authors:  Amaia Arruabarrena-Aristorena; Jesper L V Maag; Srushti Kittane; Yanyan Cai; Wouter R Karthaus; Erik Ladewig; Jane Park; Srinivasaraghavan Kannan; Lorenzo Ferrando; Emiliano Cocco; Sik Y Ho; Daisylyn S Tan; Mirna Sallaku; Fan Wu; Barbara Acevedo; Pier Selenica; Dara S Ross; Matthew Witkin; Charles L Sawyers; Jorge S Reis-Filho; Chandra S Verma; Ralf Jauch; Richard Koche; José Baselga; Pedram Razavi; Eneda Toska; Maurizio Scaltriti
Journal:  Cancer Cell       Date:  2020-09-03       Impact factor: 31.743

7.  Sex-related differences in small intestinal transit and serotonin dynamics in high-fat-diet-induced obesity in mice.

Authors:  Marion France; Emmalee Skorich; Mark Kadrofske; Greg M Swain; James J Galligan
Journal:  Exp Physiol       Date:  2015-10-28       Impact factor: 2.969

8.  Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.

Authors:  Faezeh Koohestani; Wenan Qiang; Amy L MacNeill; Stacy A Druschitz; Vanida A Serna; Malavika Adur; Takeshi Kurita; Romana A Nowak
Journal:  Hum Reprod       Date:  2016-04-29       Impact factor: 6.918

9.  Sex steroid levels and AD-like pathology in 3xTgAD mice.

Authors:  Cassia R Overk; Sylvia E Perez; Chunqi Ma; Matthew D Taves; Kiran K Soma; Elliott J Mufson
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

Review 10.  Mass spectrometry theory and application to adrenal diseases.

Authors:  Kerry M Wooding; Richard J Auchus
Journal:  Mol Cell Endocrinol       Date:  2013-01-16       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.